Cutting edge technology at HDF: Onclarity HPV test

For the first time in Lebanon, Hôtel-Dieu de France introduces the Onclarity HPV test for cervical cancer screening, a state-of-the-art technology that offers many benefits and is an alternative method to conventional practices to improve screening effectiveness.

This test is defined by the following characteristics:
- Ability to detect 14 high-risk HPV subtypes that are the direct cause of cervical cancer 
- Very high sensitivity above 95% 
- A protection period of 3 years, if negative 
- Affordable compared to other tests 

Early detection of cervical cancer plays a major role in saving women’s lives!

For more information, contact the Pathology Department of the Hôtel-Dieu de France at 01/604000 ext. 8751 or 8753.